DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Verburg FA, Stokkel MP, Duren C, Verkooijen RB, Mader U, van Isselt JW, Marlowe RJ, Smit JW, Reiners C, Luster M.
No survival difference after successful (131)I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer.
Eur J Nucl Med Mol Imaging 2010;
37: 276-283
We do not assume any responsibility for the contents of the web pages of other providers.